🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

UBS cuts Engie Brasil stock target, downgrades to sell on IRR

EditorNatashya Angelica
Published 11/11/2024, 09:06 PM
EGIEY
-

On Monday (NASDAQ:MNDY), UBS downgraded the stock of Engie Brasil Energia SA (EGIE3:BZ) (OTC: OTC:EGIEY), shifting its rating from Neutral to Sell and adjusting its price target to R$38.00, a decrease from the previous R$50.00.

The firm's analyst cited several factors influencing the downgrade, including a projected internal rate of return (IRR) that falls below the coverage average, potential negative impacts on the company's renewable generation assets, and anticipated lower results from a recent stake sale.

Engie Brasil Energia, while recognized as a strong operator with a positive history of capital allocation, faces challenges that UBS believes are significant enough to warrant a Sell rating. One key concern is the company's exposure to curtailment impacts on its newly acquired renewable generation assets, which could affect performance.

Moreover, the sale of a 15% stake in the Transportadora Associada de Gás (TAG) is expected to yield lower results than previously estimated. This sale is part of a broader concern regarding the company's net financial results, which have recently come in below UBS's projections.

The analyst also pointed out that the high capital expenditures required for new transmission lines could either constrain short-term dividend yields, reducing the stock's carry attractiveness, or lead to increased leverage for the company. UBS assumes the latter will occur, which further supports the decision to downgrade the stock.

Engie Brasil Energia's stock price is currently facing a downside potential of -6%, based on UBS's new price target. This reflects the firm's revised expectations and the various financial headwinds identified in the recent analysis.

InvestingPro Insights

While UBS has downgraded Engie Brasil Energia SA (OTC: EGIEY), InvestingPro data offers a nuanced perspective on the company's financial position. Despite the challenges highlighted by UBS, EGIEY's P/E ratio stands at a modest 7.9, suggesting the stock may be undervalued relative to its earnings. This is further supported by an InvestingPro Tip indicating that the company is trading at a low earnings multiple.

The company's financial health appears robust, with a strong operating income margin of 50.92% for the last twelve months as of Q3 2024. This high profitability metric aligns with another InvestingPro Tip noting that EGIEY has been profitable over the last twelve months.

Investors seeking income may find EGIEY's dividend yield of 3.11% attractive, especially considering the InvestingPro Tip that the company has maintained dividend payments for 24 consecutive years. This consistent dividend history could provide some reassurance to investors concerned about the potential dividend yield constraints mentioned in the UBS analysis.

For a more comprehensive analysis, InvestingPro offers additional tips and data points that could provide valuable context to the UBS downgrade. Currently, there are 5 more InvestingPro Tips available for EGIEY, which could offer further insights into the company's financial outlook and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.